Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH. Hutagalung R, et al. Among authors: jelinek t. Malar J. 2005 Sep 22;4:46. doi: 10.1186/1475-2875-4-46. Malar J. 2005. PMID: 16179089 Free PMC article. Clinical Trial.
Plasmodium falciparum in ancient Egypt.
Nerlich AG, Schraut B, Dittrich S, Jelinek T, Zink AR. Nerlich AG, et al. Among authors: jelinek t. Emerg Infect Dis. 2008 Aug;14(8):1317-9. doi: 10.3201/eid1408.080235. Emerg Infect Dis. 2008. PMID: 18680669 Free PMC article. No abstract available.
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID-19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.
Šušol O, Šušolová B, Klempíř O, Navrátil M, Gumulec J, Kořístek Z, Ďuraš J, Kaščák M, Mihályová J, Stejskal L, Jelínek T, Richterová P, Szeligová L, Plonková H, Zuchnická J, Dluhošová B, Demel I, Buffa D, Hradská K, Popková T, Muroňová L, Lachnit M, Lančová K, Hájek R. Šušol O, et al. Among authors: jelinek t. Cancer Med. 2024 Dec;13(24):e70503. doi: 10.1002/cam4.70503. Cancer Med. 2024. PMID: 39711119 Free PMC article.
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.
Diamond B, Chahar D, Jain MD, Poos AM, Durante M, Ziccheddu B, Kaddoura M, Papadimitriou M, Maclachlan K, Jelinek T, Davies F, Figura NB, Morgan G, Mai E, Weisel KC, Fenk R, Raab MS, Usmani S, Landgren O, Locke FL, Goldschmidt H, Schatz JH, Weinhold N, Maura F. Diamond B, et al. Among authors: jelinek t. bioRxiv [Preprint]. 2024 Nov 18:2024.11.15.623836. doi: 10.1101/2024.11.15.623836. bioRxiv. 2024. PMID: 39605649 Free PMC article. Preprint.
Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry.
Muronova L, Soucek O, Zihala D, Sevcikova T, Popkova T, Plonkova H, Venglar O, Pour L, Stork M, Rihova L, Bezdekova R, Minarik J, Látal V, Novak M, Jungova A, Dekojova T, Straub J, Spacek M, Rezacova V, Maisnar V, Radocha J, Hajek R, Jelinek T. Muronova L, et al. Among authors: jelinek t. Eur J Haematol. 2025 Jan;114(1):155-163. doi: 10.1111/ejh.14316. Epub 2024 Oct 10. Eur J Haematol. 2025. PMID: 39390851 Free PMC article.
Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation.
Radhakrishnan D, Kotulová J, Hofmanová L, Sithara AA, Turi M, Žihala D, Ďurech M, Vrána J, Uleri V, Niederlova V, Stepanek O, Chyra Z, Jelínek T, Hájek R, Hrdinka M. Radhakrishnan D, et al. Among authors: jelinek t. J Leukoc Biol. 2024 Dec 31;117(1):qiae184. doi: 10.1093/jleuko/qiae184. J Leukoc Biol. 2024. PMID: 39189628
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma.
John M, Helal M, Duell J, Mattavelli G, Stanojkovska E, Afrin N, Leipold AM, Steinhardt MJ, Zhou X, Žihala D, Anilkumar Sithara A, Mersi J, Waldschmidt JM, Riedhammer C, Kadel SK, Truger M, Werner RA, Haferlach C, Einsele H, Kretzschmar K, Jelínek T, Rosenwald A, Kortüm KM, Riedel A, Rasche L. John M, et al. Among authors: jelinek t. Blood. 2024 Nov 14;144(20):2121-2135. doi: 10.1182/blood.2024024590. Blood. 2024. PMID: 39172759
Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients.
Vlachová M, Pečinka L, Gregorová J, Moráň L, Růžičková T, Kovačovicová P, Almáši M, Pour L, Štork M, Hájek R, Jelínek T, Popková T, Večeřa M, Havel J, Vaňhara P, Ševčíková S. Vlachová M, et al. Among authors: jelinek t. Sci Rep. 2024 Aug 13;14(1):18777. doi: 10.1038/s41598-024-69408-1. Sci Rep. 2024. PMID: 39138296 Free PMC article.
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma.
Kapoor P, Nathwani N, Jelinek T, Pour L, Perrot A, Dimopoulos MA, Huang SY, Spicka I, Chhabra S, Lichtman E, Mateos MV, Kanagavel D, Zhao L, Guillemin-Paveau H, Macé S, van de Velde H, Richardson PG. Kapoor P, et al. Among authors: jelinek t. Eur J Haematol. 2024 Nov;113(5):593-605. doi: 10.1111/ejh.14270. Epub 2024 Jul 12. Eur J Haematol. 2024. PMID: 38993150 Clinical Trial.
303 results